• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环信使 RNA 表达的血管内皮生长因子、PTEN 和 SOCS1 作为鼻咽癌进展的潜在预后预测因子。

Circulating mRNA Expression of VEGF, PTEN, and SOCS1 as Potential Prognostic Predictor for Nasopharyngeal Carcinoma Progression.

机构信息

Department of Pathology Anatomy, Faculty of Medicine, Jenderal Soedirman University, Purwokerto, Indonesia.

Undergraduate Student, Faculty of Medicine, Jenderal Soedirman University, Purwokerto, Indonesia.

出版信息

Asian Pac J Cancer Prev. 2024 Sep 1;25(9):2999-3006. doi: 10.31557/APJCP.2024.25.9.2999.

DOI:10.31557/APJCP.2024.25.9.2999
PMID:39342576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11700339/
Abstract

BACKGROUND

The molecular mechanisms underlying nasopharyngeal carcinoma (NPC) progression remain poorly understood. In particular, the roles of circulating mRNAs encoding key regulatory proteins have yet to be explored. This study aimed to identify NPC-associated expression signatures of circulating VEGF, PTEN, and SOCS1 mRNAs and their potential as biomarkers.

METHODS

A case-control study was conducted comprising 160 nasopharyngeal carcinoma (NPC) patients and 80 controls, from whom peripheral blood samples. Total RNA was extracted and the levels of VEGF, PTEN, and SOCS1 mRNAs were quantified using reverse transcription quantitative PCR (RT-qPCR). Relative expression was calculated using the 2-ΔΔCt method. Bioinformatic analyses, including GeneMANIA, Gene Ontology (GO), and KEGG pathway analysis, were performed to predict the functional roles and interactions of these mRNAs.

RESULTS

We identified significantly increased circulating VEGF mRNA in lymph node metastases (1.66-fold, p<0.05) and elevated SOCS1 mRNA in late-stage NPC (20-fold, p<0.05). PTEN mRNA was reduced 4.26-fold in NPC patients. These data suggest that circulating VEGF, PTEN, and SOCS1 mRNAs represent signatures of NPC progression and can potentially be biomarkers. Network analyses implicate these mRNAs in mechanisms enabling NPC pathogenesis.

CONCLUSIONS

Our study reveals NPC-associated expression changes of circulating VEGF, PTEN, and SOCS1 mRNAs. These molecular signatures may serve as biomarkers during NPC progression and provide insights into underlying mechanisms. Further validation of their utility as prognostic indicators of NPC is warranted.

摘要

背景

鼻咽癌(NPC)进展的分子机制仍知之甚少。特别是,循环 mRNA 编码关键调节蛋白的作用尚未得到探索。本研究旨在鉴定 NPC 相关的循环 VEGF、PTEN 和 SOCS1 mRNA 的表达特征及其作为生物标志物的潜力。

方法

进行了一项病例对照研究,包括 160 例鼻咽癌(NPC)患者和 80 例对照,从他们的外周血样本中提取总 RNA,并使用逆转录定量 PCR(RT-qPCR)定量测定 VEGF、PTEN 和 SOCS1 mRNA 的水平。使用 2-ΔΔCt 方法计算相对表达。进行生物信息学分析,包括 GeneMANIA、基因本体论(GO)和 KEGG 途径分析,以预测这些 mRNA 的功能作用和相互作用。

结果

我们发现淋巴结转移中的循环 VEGF mRNA 显著增加(1.66 倍,p<0.05),晚期 NPC 中的 SOCS1 mRNA 升高(20 倍,p<0.05)。NPC 患者的 PTEN mRNA 减少了 4.26 倍。这些数据表明,循环 VEGF、PTEN 和 SOCS1 mRNA 代表 NPC 进展的特征,并且可能是生物标志物。网络分析表明这些 mRNA 参与了 NPC 发病机制的机制。

结论

我们的研究揭示了 NPC 相关的循环 VEGF、PTEN 和 SOCS1 mRNA 的表达变化。这些分子特征可作为 NPC 进展过程中的生物标志物,并提供对潜在机制的深入了解。需要进一步验证它们作为 NPC 预后指标的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8e/11700339/08cb24919332/APJCP-25-2999-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8e/11700339/08cb24919332/APJCP-25-2999-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8e/11700339/08cb24919332/APJCP-25-2999-g003.jpg

相似文献

1
Circulating mRNA Expression of VEGF, PTEN, and SOCS1 as Potential Prognostic Predictor for Nasopharyngeal Carcinoma Progression.循环信使 RNA 表达的血管内皮生长因子、PTEN 和 SOCS1 作为鼻咽癌进展的潜在预后预测因子。
Asian Pac J Cancer Prev. 2024 Sep 1;25(9):2999-3006. doi: 10.31557/APJCP.2024.25.9.2999.
2
Integrative analysis of miRNAs-mRNAs reveals that miR-182 up-regulation contributes to proliferation and invasion of nasopharyngeal carcinoma by targeting PTEN.miRNAs-mRNAs 整合分析显示 miR-182 通过靶向 PTEN 促进鼻咽癌的增殖和侵袭。
Aging (Albany NY). 2020 Jun 15;12(12):11568-11578. doi: 10.18632/aging.103316.
3
MicroRNA Gene Signature for Predicting Mechanisms in Nasopharyngeal Carcinoma: A Case Study on the Potential Application of Circulating Biomarkers.用于预测鼻咽癌机制的 microRNA 基因特征:循环生物标志物潜在应用的案例研究。
Microrna. 2023;12(1):29-44. doi: 10.2174/2211536611666220919144834.
4
Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.STAT3对miR-21的激活通过靶向PTEN基因诱导鼻咽癌增殖并抑制其凋亡。
PLoS One. 2014 Nov 3;9(11):e109929. doi: 10.1371/journal.pone.0109929. eCollection 2014.
5
Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.全血中两个 microRNA 特征作为鼻咽癌诊断新型生物标志物的鉴定。
J Transl Med. 2019 Jun 3;17(1):186. doi: 10.1186/s12967-019-1923-2.
6
MiR-214 Mediates Cell Proliferation and Apoptosis of Nasopharyngeal Carcinoma Through Targeting Both WWOX and PTEN.miR-214 通过靶向 WWOX 和 PTEN 介导鼻咽癌细胞的增殖和凋亡。
Cancer Biother Radiopharm. 2020 Oct;35(8):615-625. doi: 10.1089/cbr.2019.2978. Epub 2020 Feb 26.
7
MiR-2110 induced by chemically synthesized cinobufagin functions as a tumor-metastatic suppressor via targeting FGFR1 to reduce PTEN ubiquitination degradation in nasopharyngeal carcinoma.化学合成的华蟾毒精诱导的 miR-2110 通过靶向 FGFR1 减少鼻咽癌中 PTEN 的泛素化降解,从而发挥肿瘤转移抑制作用。
Environ Toxicol. 2024 Jun;39(6):3548-3562. doi: 10.1002/tox.24197. Epub 2024 Mar 13.
8
Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma.循环肿瘤细胞与纤连蛋白1在鼻咽癌预后中的作用
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820909911. doi: 10.1177/1533033820909911.
9
Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.上调的TRIM29通过PTEN/AKT/mTOR信号通路促进鼻咽癌的增殖和转移。
Oncotarget. 2016 Mar 22;7(12):13634-50. doi: 10.18632/oncotarget.7215.
10
Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker.PTEN基因启动子区异常的CpG岛甲基化是鼻咽癌发生的早期事件及潜在的诊断生物标志物。
Oncol Rep. 2014 May;31(5):2206-12. doi: 10.3892/or.2014.3061. Epub 2014 Mar 5.

本文引用的文献

1
Burden of oral cancer in Asia from 1990 to 2019: Estimates from the Global Burden of Disease 2019 study.亚洲口腔癌负担:来自 2019 年全球疾病负担研究的估计。
PLoS One. 2022 Mar 24;17(3):e0265950. doi: 10.1371/journal.pone.0265950. eCollection 2022.
2
The Evolving Epidemiology of Nasopharyngeal Carcinoma.鼻咽癌的不断演变的流行病学。
Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1035-1047. doi: 10.1158/1055-9965.EPI-20-1702. Epub 2021 Apr 13.
3
Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review).
高通量组学时代鼻咽癌生物标志物的研究现状与展望(综述)。
Int J Oncol. 2021 Apr;58(4). doi: 10.3892/ijo.2021.5188. Epub 2021 Mar 2.
4
Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival.年龄相关的鼻咽癌生存性别差异变化。
Biol Sex Differ. 2021 Jan 30;12(1):18. doi: 10.1186/s13293-021-00361-8.
5
Nasopharyngeal Carcinoma (NPC) Risk Factors: A Systematic Review and Meta-Analysis of the Association with Lifestyle, Diets, Socioeconomic and Sociodemographic in Asian Region.鼻咽癌(NPC)风险因素:亚洲地区与生活方式、饮食、社会经济和社会人口统计学关联的系统评价与荟萃分析
Asian Pac J Cancer Prev. 2019 Nov 1;20(11):3505-3514. doi: 10.31557/APJCP.2019.20.11.3505.
6
miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer.miR-150-5p通过靶向血管内皮生长因子A(VEGFA)抑制结直肠癌的肿瘤进展。
Aging (Albany NY). 2018 Nov 26;10(11):3421-3437. doi: 10.18632/aging.101656.
7
The potential of liquid biopsies for the early detection of cancer.液体活检在癌症早期检测中的潜力。
NPJ Precis Oncol. 2017 Oct 17;1(1):36. doi: 10.1038/s41698-017-0039-5. eCollection 2017.
8
The functions and regulation of the PTEN tumour suppressor: new modes and prospects.PTEN 肿瘤抑制因子的功能与调节:新模式与新前景。
Nat Rev Mol Cell Biol. 2018 Sep;19(9):547-562. doi: 10.1038/s41580-018-0015-0.
9
Nasopharyngeal carcinoma: A review of current updates.鼻咽癌:当前进展综述
Exp Ther Med. 2018 Apr;15(4):3687-3692. doi: 10.3892/etm.2018.5878. Epub 2018 Feb 20.
10
Epstein-Barr virus infection and nasopharyngeal carcinoma.爱泼斯坦-巴尔病毒感染与鼻咽癌
Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732). doi: 10.1098/rstb.2016.0270.